Phio Pharmaceuticals Corp (PHIO)

Jul 02, 2026

PHIO PE Ratio & Valuation, Is PHIO Overvalued - Intellectia AI

Jul 02, 2026

Jun 29, 2026

Phio Pharmaceuticals CEO Robert Bitterman buys $9,900 in stock - Investing.com

Jun 29, 2026

Jun 29, 2026

[Form 4] Phio Pharmaceuticals Corp. Insider Trading Activity - Stock Titan

Jun 29, 2026

Jun 29, 2026

Form 4 Phio Pharmaceuticals Corp For: 29 June By Investing.com - Investing.com South Africa

Jun 29, 2026

Jun 29, 2026

Phio Pharmaceuticals CEO Robert Bitterman buys $9,900 in stock By Investing.com - Investing.com South Africa

Jun 29, 2026

Jun 29, 2026

PHIO: PH-762 achieved strong safety and efficacy, with INTASYL poised for broader clinical impact - TradingView

Jun 29, 2026

Jun 29, 2026

PHIO: PH-762 achieved 85% response with no serious adverse events; next trial planned for early next year - TradingView

Jun 29, 2026

Jun 29, 2026

Phio Pharmaceuticals Announces "How siRNA Therapy can Change the Course of Cancer Treatment" in a Fireside Chat with Force Family Office on Monday, June 29, 2026 - TMX Newsfile

Jun 29, 2026

Jun 28, 2026

Phio Pharmaceuticals Announces Participation in the Renmark Financial Communications Live Virtual Non-Deal Roadshow Series - TMX Newsfile

Jun 28, 2026

Jun 26, 2026

Phio CEO to pitch INTASYL cancer platform in June 30 webcast - Stock Titan

Jun 26, 2026

Jun 25, 2026

Phio Pharmaceuticals (PHIO) Life Sciences Virtual Investor Forum Summary - Quartr

Jun 25, 2026

Jun 25, 2026

Phio Pharmaceuticals Reaches Key Milestone in Advancing Lead Candidate PH-762 - EIN News

Jun 25, 2026

Jun 25, 2026

PHIO Forecast — Price Target — Prediction for 2027 - TradingView

Jun 25, 2026

Jun 25, 2026

Phio Pharmaceuticals Corp. Actuals & Estimates (MUN:44R1) - TradingView

Jun 25, 2026

Jun 25, 2026

44R1 Forecast — Price Target — Prediction for 2027 - TradingView

Jun 25, 2026

Jun 24, 2026

Phio Pharmaceuticals begins commercial-scale production of PH-762 By Investing.com - Investing.com South Africa

Jun 24, 2026

Jun 24, 2026

Phio Pharmaceuticals begins commercial-scale production of PH-762 - Investing.com

Jun 24, 2026

Jun 24, 2026

Phio’s PH-762 clears a manufacturing step toward its next trial - Stock Titan

Jun 24, 2026

Jun 23, 2026

Phio Pharmaceuticals Announces Participation in the Life Sciences Investor Forum on June 24-25, 2026 - The Des Moines Register

Jun 23, 2026

Jun 22, 2026

PHIO Q1 2026 Earnings: Wider-Than-Expected Loss Weighs on SharesOne-Time Loss Impact - dars.gov.et

Jun 22, 2026

Jun 19, 2026

PHIO Should I Buy - Intellectia AI

Jun 19, 2026

Jun 18, 2026

Phio CEO to pitch INTASYL cancer platform at investor forum June 25 - Stock Titan

Jun 18, 2026

Jun 17, 2026

Phio Pharmaceuticals Corp (PHIO) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Jun 17, 2026

Jun 17, 2026

Phio Pharmaceuticals Corp (PHIO) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Jun 17, 2026

Jun 17, 2026

Phio Pharmaceuticals Corp (PHIO) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

Jun 17, 2026

Jun 17, 2026

Phio Pharmaceuticals Corp (PHIO) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Jun 17, 2026

Jun 17, 2026

Phio Pharmaceuticals Corp (PHIO) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

Jun 17, 2026

Jun 17, 2026

Phio Pharmaceuticals Corp (PHIO) Valuation: PE, PB & Fair Value Analysis - TradingKey

Jun 17, 2026

Jun 17, 2026

Phio Pharmaceuticals Corp (PHIO) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

Jun 17, 2026

Jun 17, 2026

Phio Pharmaceuticals Corp (PHIO) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

Jun 17, 2026

Jun 17, 2026

Phio Pharmaceuticals Corp (PHIO) Institutional Confidence - TradingKey

Jun 17, 2026

Jun 15, 2026

PHIO Q1 2026 Earnings: EPS Miss Widens as Clinical-Stage Biotech Continues R&D InvestmentEarnings Sentiment Score - newsline.com

Jun 15, 2026

Jun 14, 2026

PHIO Q1 2026 Earnings: Wider-than-Expected Loss Highlights Pre-Revenue ChallengesDividend Earnings Report - newsline.com

Jun 14, 2026

Jun 11, 2026

PHIO Q1 2026 Earnings: Wider-than-Expected Loss as Clinical-Stage Biotech Reports ResultsProfit Inflection Point - newsline.com

Jun 11, 2026

Jun 10, 2026

Number of shareholders of Phio Pharmaceuticals Corp. – MUN:44R1 - TradingView

Jun 10, 2026

Jun 02, 2026

Phio Pharmaceuticals Q1 2026 Earnings: EPS Misses Estimates as R&D Spending IntensifiesEarnings Growth Forecast - newsline.com

Jun 02, 2026

May 29, 2026

Phio Pharmaceuticals Slides 2.6% as Selling Pressure PersistsForce Index - newsline.com

May 29, 2026

May 28, 2026

Phio Pharmaceuticals Q1 2026 Earnings: EPS Misses Estimates as Development-Stage Biotech Reports No Revenue - The Legal Advocate

May 28, 2026

May 28, 2026

Phio Pharmaceuticals (PHIO) Edges Higher, Testing Key Resistance at $1.17Reversal Setup Alerts - newsline.com

May 28, 2026

May 27, 2026

Phio Pharmaceuticals Shares Tick Higher as CEO Hits the Road; Traders Eye Small Biotech - Bez Kabli

May 27, 2026

May 26, 2026

PHIO Q1 2026 Earnings: EPS Misses Estimates Amid Continued Clinical Trials FocusRevenue Beat Analysis - The Legal Advocate

May 26, 2026

May 26, 2026

PHIOPhio Pharmaceuticals Corp Stock Price and Quote - Finviz

May 26, 2026

May 26, 2026

Skin cancer treatment PH-762: Phio live Q&A session May 28 - Stock Titan

May 26, 2026

May 25, 2026

Phio Pharmaceuticals Holds Steady Near Support Levels; PHIO Stock Consolidates in Narrow RangeMA Cross Alert - The Legal Advocate

May 25, 2026

May 25, 2026

PHIO Q1 2026 Earnings: Wider-than-Expected Loss Reflects Ongoing R&D InvestmentInvestor Earnings Call - thelegaladvocate.com

May 25, 2026

May 24, 2026

PHIO Q1 2026 Earnings: EPS Misses Estimates as Research-Focused Biotech Maintains Development Pace - newsline.com

May 24, 2026

May 22, 2026

PHIO Stock Price, Quote & Chart | PHIO PHARMACEUTICALS CORP (NASDAQ:PHIO) - ChartMill

May 22, 2026